Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Queen Elizabeth II Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT00336115
First received: June 9, 2006
Last updated: October 22, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: May 2008
  Estimated Primary Completion Date: No date given